Zealand Pharma – Notice of Interim Report for First Nine Months of 2012 (Unaudited) and Conference Call  
11/9/2012 9:44:51 AM

Copenhagen, [9] November 2012 – Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, will announce its Interim Report for the first nine months of 2012 on Tuesday, 13 November 2012.